Problems Associated with Deprescribing of Proton Pump Inhibitors

Proton pump inhibitors (PPIs) are recommended as a first-line treatment for gastroesophageal reflux disease (GERD) and other acid related disorders. In recent years, concerns have been raised about the increasing prevalence of patients on long-term PPI therapy and inappropriate PPI use. It is well k...

Descripción completa

Detalles Bibliográficos
Autores principales: Helgadottir, Holmfridur, Bjornsson, Einar S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862638/
https://www.ncbi.nlm.nih.gov/pubmed/31684070
http://dx.doi.org/10.3390/ijms20215469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862638/
https://www.ncbi.nlm.nih.gov/pubmed/31684070
http://dx.doi.org/10.3390/ijms20215469

Ejemplares similares